InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,344.39
(
0.00%
)
US TECH 100
18,057.20
(
0.23%
)
Dow Jones
39,357.01
(
-0.36%
)
Brent Oil
81.61
(
3.03%
)
Bitcoin
59,193.88
(
0.80%
)
Post# of 252857
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rkrw

Send PM Follow Ignore
Followers 45
Posts 3204
Boards Moderated 0
Alias Born 12/29/2003

rkrw

Member Level

Re: DewDiligence post# 58381

Thursday, 01/31/2008 4:17:32 PM

Thursday, January 31, 2008 4:17:32 PM

Post# of 252857
I don't think Jerini is going to be approved. Mixed data.

Lev is the only one of the bunch seeking approval in prevention and I seriously doubt the fda won't approve. P-value was .0001. Acute data p-value was .026, so flip a couple of patients around maybe they miss. But it would take an awfully rigid fda to not clear it.

CEO didn't handle the call very well, left a lot of confusion and analysts were angry when they didn't get answers. So I think that compounded what may not have even been bad news.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up